Thread by @UroDocAsh

Join us at #AUA23 for our
2nd AUA-IBCG #BladderCancer Forum
Sun, April 30th 2 - 5 pm
@UrogerliMD @paolo_gontero @garysteinbergmd @SWilliams_MD @uromc @tbivala1 @spsutkaMD @SimaPorten @bbmdmsk @AStenzl @JoshMeeks @WesKassouf @PGrivasMDPhD @nnavai @MaxKates @shilpaonc @MariaJRibal

Let's get some polls going to help our debaters! #AUA23 #AUA2023 @IBCG_BladderCA @AmerUrological @uromc @tbivala1 @joanfundi @siadaneshmand @JimCatto @UrogerliMD @SWilliams_MD @urotoday @BladderCancerUS

Poll #1a Optimal TURBT:
Do Skilled Urologists Really Need PDD for TURBT?

Poll #1b Optimal Cystoscopy:
Do Skilled Urologists Really Need PDD for Surveillance Cystoscopy in Clinic?

#AUA23 #AUA2023 @AmerUrological @uromc @tbivala1 @siadaneshmand @MRoupret @UrogerliMD @SWilliams_MD @urotoday @BladderCancerUS @SimaPorten @drtanws @bbmdmsk @MaxKates

Poll #2a: Intermediate risk NMIBC : should we include HG tumors in IR-NMIBC?

@UrogerliMD @paolo_gontero @garysteinbergmd
@SWilliams_MD @uromc @tbivala1 @spsutkaMD
@SimaPorten @bbmdmsk @AStenzl @JoshMeeks
@WesKassouf @nnavai @MaxKates @drtanws @urotoday #AUA23

Poll #2b: If IR-NMIBC is limited to TaLG (recurrent, multiple, +/- large), what % of your patients do you manage with Active Surveillance?

@UrogerliMD @paolo_gontero @garysteinbergmd
@SWilliams_MD @spsutkaMD @SimaPorten @JoshMeeks @pcvblack @MaxKates @drtanws @urotoday #AUA23

Poll #3: Pathology or (Molecular) Markers: which is more important/informative in 2023 for #bladdercancer #AUA23
@priyaraomd @Gleason4plus5 @PGrivasMDPhD @djmcconkey @GGiannarini @MRoupret @SWilliams_MD @evacomperat
@spsutkaMD @MaxKates @shilpaonc @GU_Path_Society @LDyrskjot

Poll #4: (very) high risk NMIBC : eg T1HG, multiple, large + CIS (re-TUR -ve) in 72 yr healthy female - you recommend:

@SimaPorten @AStenzl @UrogerliMD @MRoupret @LAUrology_NL @MaxKates @SWilliams_MD @joanfundi @AlisonBirtle @UrogerliMD @Agarwal_CaB @uretericbud @LauraBukavinaMD

The diversion what works 'best' for most patients with #bladdercancer (eg 70s, 1-2 co-morbidities) is:

@spsutkaMD @bbmdmsk @joanfundi @garysteinbergmd @SimaPorten @AStenzl @urotoday @MaxKates @SWilliams_MD @UrogerliMD @siadaneshmand @GGiannarini @BladderCancerUS #AUA2023

Poll #6: In patients with N+ disease and good response to systemic therapy, you would recommend

@PGrivasMDPhD @nnavai @MaxKates @shilpaonc @montypal @Uromigos @MRoupret @Prof_Nick_James @spsutkaMD @bbmdmsk @joanfundi @pcvblack @urotoday @UrogerliMD @UroCancer #AUA23 #AUA2023

Final poll #AUA23

Bladder Preservation for MIBC: Myth or Reality? Effective in:

@shilpaonc @GGiannarini @AlisonBirtle @MaxKates @KeithKow @pcvblack @SWilliams_MD @MariaJRibal @MattGalsky @garysteinbergmd @bbmdmsk @siadaneshmand @joanfundi @uretericbud @UroCancerMD @Agarwal_CaB

@threadreaderapp unroll